nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—CYP1A1—Dacarbazine—muscle cancer	0.179	0.353	CbGbCtD
Melatonin—CYP1B1—Doxorubicin—muscle cancer	0.136	0.269	CbGbCtD
Melatonin—CYP1A2—Dacarbazine—muscle cancer	0.0799	0.158	CbGbCtD
Melatonin—SLC22A8—Methotrexate—muscle cancer	0.0728	0.144	CbGbCtD
Melatonin—CYP1A2—Etoposide—muscle cancer	0.0391	0.0772	CbGbCtD
Melatonin—EPX—bone marrow—muscle cancer	0.00886	0.0511	CbGeAlD
Melatonin—CALR—embryo—muscle cancer	0.00688	0.0396	CbGeAlD
Melatonin—MTNR1B—head—muscle cancer	0.00667	0.0384	CbGeAlD
Melatonin—ASMT—head—muscle cancer	0.0065	0.0374	CbGeAlD
Melatonin—ASMT—testis—muscle cancer	0.00628	0.0362	CbGeAlD
Melatonin—CALR—smooth muscle tissue—muscle cancer	0.00541	0.0312	CbGeAlD
Melatonin—MTNR1A—head—muscle cancer	0.00527	0.0304	CbGeAlD
Melatonin—CALR—renal system—muscle cancer	0.00521	0.03	CbGeAlD
Melatonin—MTNR1A—testis—muscle cancer	0.00509	0.0293	CbGeAlD
Melatonin—CALR—cardiac atrium—muscle cancer	0.00466	0.0269	CbGeAlD
Melatonin—MT3—head—muscle cancer	0.00442	0.0255	CbGeAlD
Melatonin—MT3—testis—muscle cancer	0.00427	0.0246	CbGeAlD
Melatonin—CALR—tendon—muscle cancer	0.00406	0.0234	CbGeAlD
Melatonin—CALR—bone marrow—muscle cancer	0.00394	0.0227	CbGeAlD
Melatonin—CALR—vagina—muscle cancer	0.00377	0.0217	CbGeAlD
Melatonin—CALR—head—muscle cancer	0.00348	0.0201	CbGeAlD
Melatonin—CALR—testis—muscle cancer	0.00337	0.0194	CbGeAlD
Melatonin—NQO2—renal system—muscle cancer	0.00294	0.0169	CbGeAlD
Melatonin—NQO2—cardiac atrium—muscle cancer	0.00263	0.0152	CbGeAlD
Melatonin—Nabumetone—PTGS2—muscle cancer	0.00239	1	CrCbGaD
Melatonin—NQO2—tendon—muscle cancer	0.00229	0.0132	CbGeAlD
Melatonin—MPO—renal system—muscle cancer	0.00226	0.013	CbGeAlD
Melatonin—NQO2—bone marrow—muscle cancer	0.00222	0.0128	CbGeAlD
Melatonin—NQO2—vagina—muscle cancer	0.00213	0.0123	CbGeAlD
Melatonin—ESR1—embryo—muscle cancer	0.00212	0.0122	CbGeAlD
Melatonin—CALM3—smooth muscle tissue—muscle cancer	0.00211	0.0122	CbGeAlD
Melatonin—CALM2—embryo—muscle cancer	0.00211	0.0121	CbGeAlD
Melatonin—CALM1—embryo—muscle cancer	0.0021	0.0121	CbGeAlD
Melatonin—Nail disorder—Etoposide—muscle cancer	0.0021	0.0171	CcSEcCtD
Melatonin—Hypocalcaemia—Dactinomycin—muscle cancer	0.00205	0.0167	CcSEcCtD
Melatonin—NQO2—head—muscle cancer	0.00197	0.0113	CbGeAlD
Melatonin—NQO2—testis—muscle cancer	0.0019	0.0109	CbGeAlD
Melatonin—CALM3—cardiac atrium—muscle cancer	0.00182	0.0105	CbGeAlD
Melatonin—SLC22A8—renal system—muscle cancer	0.00181	0.0104	CbGeAlD
Melatonin—CYP1B1—smooth muscle tissue—muscle cancer	0.00179	0.0103	CbGeAlD
Melatonin—CYP1B1—renal system—muscle cancer	0.00173	0.00995	CbGeAlD
Melatonin—MPO—bone marrow—muscle cancer	0.00171	0.00985	CbGeAlD
Melatonin—Mouth ulceration—Dactinomycin—muscle cancer	0.0017	0.0138	CcSEcCtD
Melatonin—Laboratory test abnormal—Doxorubicin—muscle cancer	0.00169	0.0138	CcSEcCtD
Melatonin—ESR1—smooth muscle tissue—muscle cancer	0.00167	0.00961	CbGeAlD
Melatonin—CALM2—smooth muscle tissue—muscle cancer	0.00166	0.00955	CbGeAlD
Melatonin—CALM1—smooth muscle tissue—muscle cancer	0.00165	0.00951	CbGeAlD
Melatonin—ESR1—renal system—muscle cancer	0.00161	0.00925	CbGeAlD
Melatonin—CALM2—renal system—muscle cancer	0.0016	0.00919	CbGeAlD
Melatonin—CALM1—renal system—muscle cancer	0.00159	0.00915	CbGeAlD
Melatonin—CALM3—tendon—muscle cancer	0.00159	0.00914	CbGeAlD
Melatonin—CALM3—bone marrow—muscle cancer	0.00154	0.00885	CbGeAlD
Melatonin—Urine output increased—Vincristine—muscle cancer	0.00152	0.0124	CcSEcCtD
Melatonin—Mouth ulceration—Vincristine—muscle cancer	0.00152	0.0124	CcSEcCtD
Melatonin—MPO—head—muscle cancer	0.00151	0.00872	CbGeAlD
Melatonin—CALM3—vagina—muscle cancer	0.00147	0.00848	CbGeAlD
Melatonin—MPO—testis—muscle cancer	0.00146	0.00842	CbGeAlD
Melatonin—CALM2—cardiac atrium—muscle cancer	0.00143	0.00823	CbGeAlD
Melatonin—CALM1—cardiac atrium—muscle cancer	0.00142	0.0082	CbGeAlD
Melatonin—Lethargy—Dactinomycin—muscle cancer	0.00139	0.0113	CcSEcCtD
Melatonin—Polyuria—Vincristine—muscle cancer	0.00139	0.0113	CcSEcCtD
Melatonin—CYP1B1—tendon—muscle cancer	0.00135	0.00777	CbGeAlD
Melatonin—CALM3—testis—muscle cancer	0.00131	0.00757	CbGeAlD
Melatonin—Psoriasis—Methotrexate—muscle cancer	0.0013	0.0106	CcSEcCtD
Melatonin—Liver function test abnormal—Dactinomycin—muscle cancer	0.00126	0.0103	CcSEcCtD
Melatonin—Nail disorder—Methotrexate—muscle cancer	0.00126	0.0102	CcSEcCtD
Melatonin—CALM2—tendon—muscle cancer	0.00125	0.00718	CbGeAlD
Melatonin—CALM1—tendon—muscle cancer	0.00124	0.00714	CbGeAlD
Melatonin—CYP1A2—renal system—muscle cancer	0.00124	0.00713	CbGeAlD
Melatonin—CYP19A1—head—muscle cancer	0.00124	0.00712	CbGeAlD
Melatonin—Mouth ulceration—Etoposide—muscle cancer	0.00123	0.01	CcSEcCtD
Melatonin—Hyponatraemia—Vincristine—muscle cancer	0.00122	0.00997	CcSEcCtD
Melatonin—CYP1A1—renal system—muscle cancer	0.00122	0.00703	CbGeAlD
Melatonin—Pain in extremity—Vincristine—muscle cancer	0.00122	0.00993	CcSEcCtD
Melatonin—SLC22A8—head—muscle cancer	0.00121	0.00697	CbGeAlD
Melatonin—CALM2—bone marrow—muscle cancer	0.00121	0.00695	CbGeAlD
Melatonin—CALM1—bone marrow—muscle cancer	0.0012	0.00692	CbGeAlD
Melatonin—CYP19A1—testis—muscle cancer	0.00119	0.00688	CbGeAlD
Melatonin—ESR1—vagina—muscle cancer	0.00116	0.0067	CbGeAlD
Melatonin—CALM2—vagina—muscle cancer	0.00116	0.00666	CbGeAlD
Melatonin—CYP1B1—head—muscle cancer	0.00116	0.00666	CbGeAlD
Melatonin—CALM1—vagina—muscle cancer	0.00115	0.00663	CbGeAlD
Melatonin—Psoriasis—Doxorubicin—muscle cancer	0.00112	0.00914	CcSEcCtD
Melatonin—CYP1B1—testis—muscle cancer	0.00112	0.00643	CbGeAlD
Melatonin—CYP2C19—vagina—muscle cancer	0.0011	0.00632	CbGeAlD
Melatonin—CYP1A1—cardiac atrium—muscle cancer	0.00109	0.0063	CbGeAlD
Melatonin—Nail disorder—Doxorubicin—muscle cancer	0.00109	0.00886	CcSEcCtD
Melatonin—Herpes zoster—Methotrexate—muscle cancer	0.00108	0.00881	CcSEcCtD
Melatonin—ESR1—head—muscle cancer	0.00107	0.00619	CbGeAlD
Melatonin—CALM2—head—muscle cancer	0.00107	0.00615	CbGeAlD
Melatonin—CALM1—head—muscle cancer	0.00106	0.00612	CbGeAlD
Melatonin—ESR1—testis—muscle cancer	0.00104	0.00598	CbGeAlD
Melatonin—CALM2—testis—muscle cancer	0.00103	0.00594	CbGeAlD
Melatonin—CALM1—testis—muscle cancer	0.00103	0.00592	CbGeAlD
Melatonin—Stomatitis—Dactinomycin—muscle cancer	0.00103	0.00835	CcSEcCtD
Melatonin—Herpes zoster—Doxorubicin—muscle cancer	0.000937	0.00763	CcSEcCtD
Melatonin—Proteinuria—Methotrexate—muscle cancer	0.000928	0.00755	CcSEcCtD
Melatonin—Stomatitis—Vincristine—muscle cancer	0.000916	0.00746	CcSEcCtD
Melatonin—Protein urine present—Methotrexate—muscle cancer	0.000915	0.00745	CcSEcCtD
Melatonin—Hyperbilirubinaemia—Methotrexate—muscle cancer	0.000896	0.0073	CcSEcCtD
Melatonin—CYP1A1—vagina—muscle cancer	0.000884	0.0051	CbGeAlD
Melatonin—Glycosuria—Doxorubicin—muscle cancer	0.000871	0.00709	CcSEcCtD
Melatonin—Hepatic enzyme increased—Methotrexate—muscle cancer	0.000862	0.00701	CcSEcCtD
Melatonin—Urinary tract disorder—Vincristine—muscle cancer	0.000833	0.00678	CcSEcCtD
Melatonin—Connective tissue disorder—Vincristine—muscle cancer	0.000829	0.00675	CcSEcCtD
Melatonin—Urethral disorder—Vincristine—muscle cancer	0.000827	0.00673	CcSEcCtD
Melatonin—Erythema—Dactinomycin—muscle cancer	0.000822	0.00669	CcSEcCtD
Melatonin—CYP1A1—head—muscle cancer	0.000817	0.00471	CbGeAlD
Melatonin—Cardiac disorder—Vincristine—muscle cancer	0.000783	0.00637	CcSEcCtD
Melatonin—Hyperbilirubinaemia—Doxorubicin—muscle cancer	0.000776	0.00632	CcSEcCtD
Melatonin—Hypocalcaemia—Doxorubicin—muscle cancer	0.000771	0.00628	CcSEcCtD
Melatonin—Lacrimation increased—Doxorubicin—muscle cancer	0.000766	0.00623	CcSEcCtD
Melatonin—Angiopathy—Vincristine—muscle cancer	0.000765	0.00623	CcSEcCtD
Melatonin—Infestation NOS—Etoposide—muscle cancer	0.000761	0.0062	CcSEcCtD
Melatonin—Infestation—Etoposide—muscle cancer	0.000761	0.0062	CcSEcCtD
Melatonin—Nocturia—Doxorubicin—muscle cancer	0.000761	0.00619	CcSEcCtD
Melatonin—Stomatitis—Etoposide—muscle cancer	0.000742	0.00604	CcSEcCtD
Melatonin—Mental disorder—Vincristine—muscle cancer	0.000739	0.00602	CcSEcCtD
Melatonin—Urine output increased—Methotrexate—muscle cancer	0.000737	0.006	CcSEcCtD
Melatonin—Mouth ulceration—Methotrexate—muscle cancer	0.000737	0.006	CcSEcCtD
Melatonin—Leukopenia—Dactinomycin—muscle cancer	0.000736	0.00599	CcSEcCtD
Melatonin—Hepatobiliary disease—Etoposide—muscle cancer	0.00072	0.00586	CcSEcCtD
Melatonin—Neck pain—Doxorubicin—muscle cancer	0.000714	0.00582	CcSEcCtD
Melatonin—Back pain—Vincristine—muscle cancer	0.00071	0.00578	CcSEcCtD
Melatonin—Abnormal dreams—Doxorubicin—muscle cancer	0.000698	0.00568	CcSEcCtD
Melatonin—Salivary hypersecretion—Doxorubicin—muscle cancer	0.000685	0.00558	CcSEcCtD
Melatonin—Urinary tract disorder—Etoposide—muscle cancer	0.000675	0.00549	CcSEcCtD
Melatonin—Agitation—Vincristine—muscle cancer	0.000675	0.00549	CcSEcCtD
Melatonin—Polyuria—Methotrexate—muscle cancer	0.000674	0.00549	CcSEcCtD
Melatonin—Urethral disorder—Etoposide—muscle cancer	0.00067	0.00545	CcSEcCtD
Melatonin—Infection—Dactinomycin—muscle cancer	0.000666	0.00542	CcSEcCtD
Melatonin—Vertigo—Vincristine—muscle cancer	0.00066	0.00537	CcSEcCtD
Melatonin—Leukopenia—Vincristine—muscle cancer	0.000657	0.00535	CcSEcCtD
Melatonin—Thrombocytopenia—Dactinomycin—muscle cancer	0.000657	0.00535	CcSEcCtD
Melatonin—Eye disorder—Etoposide—muscle cancer	0.000639	0.0052	CcSEcCtD
Melatonin—Mouth ulceration—Doxorubicin—muscle cancer	0.000638	0.00519	CcSEcCtD
Melatonin—Cardiac disorder—Etoposide—muscle cancer	0.000634	0.00516	CcSEcCtD
Melatonin—Hypertension—Vincristine—muscle cancer	0.000634	0.00516	CcSEcCtD
Melatonin—Angiopathy—Etoposide—muscle cancer	0.00062	0.00505	CcSEcCtD
Melatonin—Immune system disorder—Etoposide—muscle cancer	0.000617	0.00502	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000611	0.00497	CcSEcCtD
Melatonin—Lethargy—Methotrexate—muscle cancer	0.000604	0.00491	CcSEcCtD
Melatonin—Infection—Vincristine—muscle cancer	0.000595	0.00485	CcSEcCtD
Melatonin—Nervous system disorder—Vincristine—muscle cancer	0.000588	0.00478	CcSEcCtD
Melatonin—Thrombocytopenia—Vincristine—muscle cancer	0.000587	0.00478	CcSEcCtD
Melatonin—Fatigue—Dactinomycin—muscle cancer	0.000578	0.00471	CcSEcCtD
Melatonin—Back pain—Etoposide—muscle cancer	0.000575	0.00468	CcSEcCtD
Melatonin—Pain—Dactinomycin—muscle cancer	0.000574	0.00467	CcSEcCtD
Melatonin—Muscle spasms—Etoposide—muscle cancer	0.000572	0.00466	CcSEcCtD
Melatonin—Eczema—Doxorubicin—muscle cancer	0.00057	0.00464	CcSEcCtD
Melatonin—Irritability—Methotrexate—muscle cancer	0.000565	0.0046	CcSEcCtD
Melatonin—Mood swings—Methotrexate—muscle cancer	0.000561	0.00456	CcSEcCtD
Melatonin—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000549	0.00447	CcSEcCtD
Melatonin—Hot flush—Doxorubicin—muscle cancer	0.000548	0.00446	CcSEcCtD
Melatonin—Liver function test abnormal—Methotrexate—muscle cancer	0.000546	0.00445	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000546	0.00444	CcSEcCtD
Melatonin—Menopausal symptoms—Doxorubicin—muscle cancer	0.000543	0.00442	CcSEcCtD
Melatonin—Insomnia—Vincristine—muscle cancer	0.000542	0.00441	CcSEcCtD
Melatonin—Paraesthesia—Vincristine—muscle cancer	0.000538	0.00438	CcSEcCtD
Melatonin—Breast disorder—Methotrexate—muscle cancer	0.000535	0.00435	CcSEcCtD
Melatonin—Vertigo—Etoposide—muscle cancer	0.000534	0.00435	CcSEcCtD
Melatonin—Leukopenia—Etoposide—muscle cancer	0.000533	0.00433	CcSEcCtD
Melatonin—Abdominal pain—Dactinomycin—muscle cancer	0.00053	0.00432	CcSEcCtD
Melatonin—Loss of consciousness—Etoposide—muscle cancer	0.000523	0.00426	CcSEcCtD
Melatonin—Lethargy—Doxorubicin—muscle cancer	0.000523	0.00426	CcSEcCtD
Melatonin—Gastrointestinal disorder—Vincristine—muscle cancer	0.000517	0.00421	CcSEcCtD
Melatonin—Fatigue—Vincristine—muscle cancer	0.000517	0.00421	CcSEcCtD
Melatonin—Hyponatraemia—Doxorubicin—muscle cancer	0.000514	0.00419	CcSEcCtD
Melatonin—Hypertension—Etoposide—muscle cancer	0.000514	0.00418	CcSEcCtD
Melatonin—Pain—Vincristine—muscle cancer	0.000513	0.00417	CcSEcCtD
Melatonin—Pain in extremity—Doxorubicin—muscle cancer	0.000512	0.00417	CcSEcCtD
Melatonin—Chest pain—Etoposide—muscle cancer	0.000506	0.00412	CcSEcCtD
Melatonin—Migraine—Doxorubicin—muscle cancer	0.000504	0.0041	CcSEcCtD
Melatonin—Affect lability—Doxorubicin—muscle cancer	0.000504	0.0041	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000503	0.00409	CcSEcCtD
Melatonin—Hypersensitivity—Dactinomycin—muscle cancer	0.000494	0.00402	CcSEcCtD
Melatonin—Abdominal discomfort—Methotrexate—muscle cancer	0.00049	0.00399	CcSEcCtD
Melatonin—Gastrointestinal pain—Vincristine—muscle cancer	0.00049	0.00399	CcSEcCtD
Melatonin—Mood swings—Doxorubicin—muscle cancer	0.000485	0.00395	CcSEcCtD
Melatonin—Infection—Etoposide—muscle cancer	0.000482	0.00393	CcSEcCtD
Melatonin—Asthenia—Dactinomycin—muscle cancer	0.000481	0.00392	CcSEcCtD
Melatonin—Thrombocytopenia—Etoposide—muscle cancer	0.000475	0.00387	CcSEcCtD
Melatonin—Abdominal pain—Vincristine—muscle cancer	0.000474	0.00386	CcSEcCtD
Melatonin—Liver function test abnormal—Doxorubicin—muscle cancer	0.000473	0.00385	CcSEcCtD
Melatonin—Skin disorder—Etoposide—muscle cancer	0.000472	0.00384	CcSEcCtD
Melatonin—Dry skin—Doxorubicin—muscle cancer	0.00047	0.00382	CcSEcCtD
Melatonin—Abdominal pain upper—Doxorubicin—muscle cancer	0.000468	0.00381	CcSEcCtD
Melatonin—Breast disorder—Doxorubicin—muscle cancer	0.000463	0.00377	CcSEcCtD
Melatonin—Nasopharyngitis—Doxorubicin—muscle cancer	0.000458	0.00373	CcSEcCtD
Melatonin—Infestation NOS—Methotrexate—muscle cancer	0.000456	0.00371	CcSEcCtD
Melatonin—Infestation—Methotrexate—muscle cancer	0.000456	0.00371	CcSEcCtD
Melatonin—Gastritis—Doxorubicin—muscle cancer	0.000453	0.00369	CcSEcCtD
Melatonin—Stomatitis—Methotrexate—muscle cancer	0.000444	0.00362	CcSEcCtD
Melatonin—Hypersensitivity—Vincristine—muscle cancer	0.000442	0.00359	CcSEcCtD
Melatonin—Paraesthesia—Etoposide—muscle cancer	0.000436	0.00355	CcSEcCtD
Melatonin—Haematuria—Methotrexate—muscle cancer	0.000435	0.00354	CcSEcCtD
Melatonin—Somnolence—Etoposide—muscle cancer	0.000432	0.00351	CcSEcCtD
Melatonin—Angina pectoris—Doxorubicin—muscle cancer	0.000431	0.00351	CcSEcCtD
Melatonin—Hepatobiliary disease—Methotrexate—muscle cancer	0.000431	0.00351	CcSEcCtD
Melatonin—Asthenia—Vincristine—muscle cancer	0.00043	0.0035	CcSEcCtD
Melatonin—Vomiting—Dactinomycin—muscle cancer	0.000427	0.00347	CcSEcCtD
Melatonin—Rash—Dactinomycin—muscle cancer	0.000423	0.00344	CcSEcCtD
Melatonin—Gastrointestinal disorder—Etoposide—muscle cancer	0.000419	0.00341	CcSEcCtD
Melatonin—Fatigue—Etoposide—muscle cancer	0.000419	0.00341	CcSEcCtD
Melatonin—Pain—Etoposide—muscle cancer	0.000415	0.00338	CcSEcCtD
Melatonin—Urinary tract disorder—Methotrexate—muscle cancer	0.000404	0.00329	CcSEcCtD
Melatonin—Weight increased—Doxorubicin—muscle cancer	0.000403	0.00328	CcSEcCtD
Melatonin—Urethral disorder—Methotrexate—muscle cancer	0.000401	0.00327	CcSEcCtD
Melatonin—Nausea—Dactinomycin—muscle cancer	0.000398	0.00324	CcSEcCtD
Melatonin—Gastrointestinal pain—Etoposide—muscle cancer	0.000397	0.00323	CcSEcCtD
Melatonin—Dizziness—Vincristine—muscle cancer	0.000396	0.00323	CcSEcCtD
Melatonin—Infestation—Doxorubicin—muscle cancer	0.000395	0.00321	CcSEcCtD
Melatonin—Infestation NOS—Doxorubicin—muscle cancer	0.000395	0.00321	CcSEcCtD
Melatonin—Stomatitis—Doxorubicin—muscle cancer	0.000385	0.00313	CcSEcCtD
Melatonin—Abdominal pain—Etoposide—muscle cancer	0.000384	0.00312	CcSEcCtD
Melatonin—Eye disorder—Methotrexate—muscle cancer	0.000383	0.00311	CcSEcCtD
Melatonin—Vomiting—Vincristine—muscle cancer	0.000381	0.0031	CcSEcCtD
Melatonin—Cardiac disorder—Methotrexate—muscle cancer	0.00038	0.00309	CcSEcCtD
Melatonin—Rash—Vincristine—muscle cancer	0.000378	0.00308	CcSEcCtD
Melatonin—Dermatitis—Vincristine—muscle cancer	0.000378	0.00307	CcSEcCtD
Melatonin—Haematuria—Doxorubicin—muscle cancer	0.000376	0.00306	CcSEcCtD
Melatonin—Headache—Vincristine—muscle cancer	0.000375	0.00306	CcSEcCtD
Melatonin—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000373	0.00304	CcSEcCtD
Melatonin—Angiopathy—Methotrexate—muscle cancer	0.000371	0.00302	CcSEcCtD
Melatonin—Immune system disorder—Methotrexate—muscle cancer	0.00037	0.00301	CcSEcCtD
Melatonin—Mental disorder—Methotrexate—muscle cancer	0.000359	0.00292	CcSEcCtD
Melatonin—Hypersensitivity—Etoposide—muscle cancer	0.000358	0.00291	CcSEcCtD
Melatonin—Erythema—Methotrexate—muscle cancer	0.000356	0.0029	CcSEcCtD
Melatonin—Malnutrition—Methotrexate—muscle cancer	0.000356	0.0029	CcSEcCtD
Melatonin—Nausea—Vincristine—muscle cancer	0.000356	0.0029	CcSEcCtD
Melatonin—Urinary tract disorder—Doxorubicin—muscle cancer	0.00035	0.00285	CcSEcCtD
Melatonin—Asthenia—Etoposide—muscle cancer	0.000348	0.00284	CcSEcCtD
Melatonin—Connective tissue disorder—Doxorubicin—muscle cancer	0.000348	0.00284	CcSEcCtD
Melatonin—Urethral disorder—Doxorubicin—muscle cancer	0.000347	0.00283	CcSEcCtD
Melatonin—Back pain—Methotrexate—muscle cancer	0.000345	0.00281	CcSEcCtD
Melatonin—Pruritus—Etoposide—muscle cancer	0.000344	0.0028	CcSEcCtD
Melatonin—Vision blurred—Methotrexate—muscle cancer	0.000336	0.00273	CcSEcCtD
Melatonin—Eye disorder—Doxorubicin—muscle cancer	0.000331	0.0027	CcSEcCtD
Melatonin—Cardiac disorder—Doxorubicin—muscle cancer	0.000329	0.00268	CcSEcCtD
Melatonin—Angiopathy—Doxorubicin—muscle cancer	0.000322	0.00262	CcSEcCtD
Melatonin—Dizziness—Etoposide—muscle cancer	0.000321	0.00261	CcSEcCtD
Melatonin—Immune system disorder—Doxorubicin—muscle cancer	0.00032	0.00261	CcSEcCtD
Melatonin—Vertigo—Methotrexate—muscle cancer	0.00032	0.00261	CcSEcCtD
Melatonin—Leukopenia—Methotrexate—muscle cancer	0.000319	0.0026	CcSEcCtD
Melatonin—Mental disorder—Doxorubicin—muscle cancer	0.000311	0.00253	CcSEcCtD
Melatonin—Vomiting—Etoposide—muscle cancer	0.000309	0.00251	CcSEcCtD
Melatonin—Erythema—Doxorubicin—muscle cancer	0.000309	0.00251	CcSEcCtD
Melatonin—Malnutrition—Doxorubicin—muscle cancer	0.000309	0.00251	CcSEcCtD
Melatonin—Rash—Etoposide—muscle cancer	0.000306	0.00249	CcSEcCtD
Melatonin—Dermatitis—Etoposide—muscle cancer	0.000306	0.00249	CcSEcCtD
Melatonin—Headache—Etoposide—muscle cancer	0.000304	0.00248	CcSEcCtD
Melatonin—Flatulence—Doxorubicin—muscle cancer	0.000304	0.00247	CcSEcCtD
Melatonin—Arthralgia—Methotrexate—muscle cancer	0.000303	0.00247	CcSEcCtD
Melatonin—Chest pain—Methotrexate—muscle cancer	0.000303	0.00247	CcSEcCtD
Melatonin—Tension—Doxorubicin—muscle cancer	0.000303	0.00246	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000301	0.00245	CcSEcCtD
Melatonin—Nervousness—Doxorubicin—muscle cancer	0.0003	0.00244	CcSEcCtD
Melatonin—Back pain—Doxorubicin—muscle cancer	0.000298	0.00243	CcSEcCtD
Melatonin—Muscle spasms—Doxorubicin—muscle cancer	0.000297	0.00241	CcSEcCtD
Melatonin—Vision blurred—Doxorubicin—muscle cancer	0.000291	0.00237	CcSEcCtD
Melatonin—Infection—Methotrexate—muscle cancer	0.000289	0.00235	CcSEcCtD
Melatonin—Nausea—Etoposide—muscle cancer	0.000288	0.00235	CcSEcCtD
Melatonin—Nervous system disorder—Methotrexate—muscle cancer	0.000285	0.00232	CcSEcCtD
Melatonin—Thrombocytopenia—Methotrexate—muscle cancer	0.000285	0.00232	CcSEcCtD
Melatonin—Agitation—Doxorubicin—muscle cancer	0.000284	0.00231	CcSEcCtD
Melatonin—Skin disorder—Methotrexate—muscle cancer	0.000282	0.0023	CcSEcCtD
Melatonin—Vertigo—Doxorubicin—muscle cancer	0.000277	0.00226	CcSEcCtD
Melatonin—Syncope—Doxorubicin—muscle cancer	0.000277	0.00225	CcSEcCtD
Melatonin—Leukopenia—Doxorubicin—muscle cancer	0.000276	0.00225	CcSEcCtD
Melatonin—Palpitations—Doxorubicin—muscle cancer	0.000273	0.00222	CcSEcCtD
Melatonin—Loss of consciousness—Doxorubicin—muscle cancer	0.000271	0.00221	CcSEcCtD
Melatonin—Hypertension—Doxorubicin—muscle cancer	0.000266	0.00217	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000265	0.00216	CcSEcCtD
Melatonin—Insomnia—Methotrexate—muscle cancer	0.000263	0.00214	CcSEcCtD
Melatonin—Arthralgia—Doxorubicin—muscle cancer	0.000263	0.00214	CcSEcCtD
Melatonin—Chest pain—Doxorubicin—muscle cancer	0.000263	0.00214	CcSEcCtD
Melatonin—Anxiety—Doxorubicin—muscle cancer	0.000262	0.00213	CcSEcCtD
Melatonin—Paraesthesia—Methotrexate—muscle cancer	0.000261	0.00213	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000261	0.00212	CcSEcCtD
Melatonin—Somnolence—Methotrexate—muscle cancer	0.000259	0.0021	CcSEcCtD
Melatonin—Dry mouth—Doxorubicin—muscle cancer	0.000257	0.00209	CcSEcCtD
Melatonin—Dyspepsia—Methotrexate—muscle cancer	0.000256	0.00208	CcSEcCtD
Melatonin—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000251	0.00204	CcSEcCtD
Melatonin—Fatigue—Methotrexate—muscle cancer	0.000251	0.00204	CcSEcCtD
Melatonin—Infection—Doxorubicin—muscle cancer	0.00025	0.00204	CcSEcCtD
Melatonin—Pain—Methotrexate—muscle cancer	0.000249	0.00202	CcSEcCtD
Melatonin—Shock—Doxorubicin—muscle cancer	0.000248	0.00202	CcSEcCtD
Melatonin—Nervous system disorder—Doxorubicin—muscle cancer	0.000247	0.00201	CcSEcCtD
Melatonin—Thrombocytopenia—Doxorubicin—muscle cancer	0.000247	0.00201	CcSEcCtD
Melatonin—Skin disorder—Doxorubicin—muscle cancer	0.000245	0.00199	CcSEcCtD
Melatonin—Gastrointestinal pain—Methotrexate—muscle cancer	0.000238	0.00194	CcSEcCtD
Melatonin—Abdominal pain—Methotrexate—muscle cancer	0.00023	0.00187	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000229	0.00187	CcSEcCtD
Melatonin—Insomnia—Doxorubicin—muscle cancer	0.000228	0.00185	CcSEcCtD
Melatonin—Paraesthesia—Doxorubicin—muscle cancer	0.000226	0.00184	CcSEcCtD
Melatonin—Somnolence—Doxorubicin—muscle cancer	0.000224	0.00182	CcSEcCtD
Melatonin—Dyspepsia—Doxorubicin—muscle cancer	0.000222	0.0018	CcSEcCtD
Melatonin—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000217	0.00177	CcSEcCtD
Melatonin—Fatigue—Doxorubicin—muscle cancer	0.000217	0.00177	CcSEcCtD
Melatonin—Pain—Doxorubicin—muscle cancer	0.000215	0.00175	CcSEcCtD
Melatonin—Hypersensitivity—Methotrexate—muscle cancer	0.000214	0.00174	CcSEcCtD
Melatonin—Asthenia—Methotrexate—muscle cancer	0.000209	0.0017	CcSEcCtD
Melatonin—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000206	0.00168	CcSEcCtD
Melatonin—Pruritus—Methotrexate—muscle cancer	0.000206	0.00167	CcSEcCtD
Melatonin—Abdominal pain—Doxorubicin—muscle cancer	0.000199	0.00162	CcSEcCtD
Melatonin—Dizziness—Methotrexate—muscle cancer	0.000192	0.00157	CcSEcCtD
Melatonin—Hypersensitivity—Doxorubicin—muscle cancer	0.000186	0.00151	CcSEcCtD
Melatonin—Vomiting—Methotrexate—muscle cancer	0.000185	0.00151	CcSEcCtD
Melatonin—Rash—Methotrexate—muscle cancer	0.000183	0.00149	CcSEcCtD
Melatonin—Dermatitis—Methotrexate—muscle cancer	0.000183	0.00149	CcSEcCtD
Melatonin—Headache—Methotrexate—muscle cancer	0.000182	0.00148	CcSEcCtD
Melatonin—Asthenia—Doxorubicin—muscle cancer	0.000181	0.00147	CcSEcCtD
Melatonin—Pruritus—Doxorubicin—muscle cancer	0.000178	0.00145	CcSEcCtD
Melatonin—Nausea—Methotrexate—muscle cancer	0.000173	0.00141	CcSEcCtD
Melatonin—Dizziness—Doxorubicin—muscle cancer	0.000167	0.00136	CcSEcCtD
Melatonin—Vomiting—Doxorubicin—muscle cancer	0.00016	0.0013	CcSEcCtD
Melatonin—Rash—Doxorubicin—muscle cancer	0.000159	0.00129	CcSEcCtD
Melatonin—Dermatitis—Doxorubicin—muscle cancer	0.000159	0.00129	CcSEcCtD
Melatonin—Headache—Doxorubicin—muscle cancer	0.000158	0.00128	CcSEcCtD
Melatonin—Nausea—Doxorubicin—muscle cancer	0.00015	0.00122	CcSEcCtD
Melatonin—CALM1—Signaling by PDGF—KIT—muscle cancer	0.00014	0.000717	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—CD34—muscle cancer	0.000139	0.000716	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—CD34—muscle cancer	0.000139	0.000716	CbGpPWpGaD
Melatonin—CALR—Disease—MDM2—muscle cancer	0.000138	0.000709	CbGpPWpGaD
Melatonin—CALM3—B Cell Activation—KIT—muscle cancer	0.000136	0.000702	CbGpPWpGaD
Melatonin—CALM1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—muscle cancer	0.000136	0.000697	CbGpPWpGaD
Melatonin—CALM2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—muscle cancer	0.000136	0.000697	CbGpPWpGaD
Melatonin—CALM3—Downstream signaling of activated FGFR—MDM2—muscle cancer	0.000133	0.000686	CbGpPWpGaD
Melatonin—CALR—Disease—PTGS2—muscle cancer	0.000133	0.000683	CbGpPWpGaD
Melatonin—CALM2—B Cell Activation—KIT—muscle cancer	0.000132	0.000679	CbGpPWpGaD
Melatonin—CALM1—B Cell Activation—KIT—muscle cancer	0.000132	0.000679	CbGpPWpGaD
Melatonin—CALM3—VEGFA-VEGFR2 Pathway—VEGFA—muscle cancer	0.000132	0.000678	CbGpPWpGaD
Melatonin—CALM3—Signaling by NGF—FOXO1—muscle cancer	0.000132	0.000678	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000131	0.000676	CbGpPWpGaD
Melatonin—CALM3—NGF signalling via TRKA from the plasma membrane—KIT—muscle cancer	0.000131	0.000672	CbGpPWpGaD
Melatonin—CALM1—Downstream signaling of activated FGFR—MDM2—muscle cancer	0.000129	0.000663	CbGpPWpGaD
Melatonin—CALM2—Downstream signaling of activated FGFR—MDM2—muscle cancer	0.000129	0.000663	CbGpPWpGaD
Melatonin—CALM2—VEGFA-VEGFR2 Pathway—VEGFA—muscle cancer	0.000128	0.000656	CbGpPWpGaD
Melatonin—CALM1—VEGFA-VEGFR2 Pathway—VEGFA—muscle cancer	0.000128	0.000656	CbGpPWpGaD
Melatonin—CALM2—Signaling by NGF—FOXO1—muscle cancer	0.000128	0.000656	CbGpPWpGaD
Melatonin—CALM1—Signaling by NGF—FOXO1—muscle cancer	0.000128	0.000656	CbGpPWpGaD
Melatonin—CALM3—Alzheimers Disease—TP53—muscle cancer	0.000127	0.000653	CbGpPWpGaD
Melatonin—CALM2—NGF signalling via TRKA from the plasma membrane—KIT—muscle cancer	0.000126	0.00065	CbGpPWpGaD
Melatonin—CALM1—NGF signalling via TRKA from the plasma membrane—KIT—muscle cancer	0.000126	0.00065	CbGpPWpGaD
Melatonin—CALM3—Downstream signal transduction—MDM2—muscle cancer	0.000125	0.000644	CbGpPWpGaD
Melatonin—CALM3—Signaling by FGFR—MDM2—muscle cancer	0.000125	0.000641	CbGpPWpGaD
Melatonin—CALM3—Signaling by VEGF—VEGFA—muscle cancer	0.000125	0.00064	CbGpPWpGaD
Melatonin—CALM3—Signaling by ERBB2—MDM2—muscle cancer	0.000124	0.000638	CbGpPWpGaD
Melatonin—CALM3—DAP12 signaling—MDM2—muscle cancer	0.000123	0.000635	CbGpPWpGaD
Melatonin—CALM1—Alzheimers Disease—TP53—muscle cancer	0.000123	0.000632	CbGpPWpGaD
Melatonin—CALM2—Alzheimers Disease—TP53—muscle cancer	0.000123	0.000632	CbGpPWpGaD
Melatonin—CALM1—Downstream signal transduction—MDM2—muscle cancer	0.000121	0.000623	CbGpPWpGaD
Melatonin—CALM2—Downstream signal transduction—MDM2—muscle cancer	0.000121	0.000623	CbGpPWpGaD
Melatonin—CYP19A1—Integrated Breast Cancer Pathway—TP53—muscle cancer	0.000121	0.000623	CbGpPWpGaD
Melatonin—CALM2—Signaling by FGFR—MDM2—muscle cancer	0.000121	0.00062	CbGpPWpGaD
Melatonin—CALM1—Signaling by FGFR—MDM2—muscle cancer	0.000121	0.00062	CbGpPWpGaD
Melatonin—CALM2—Signaling by VEGF—VEGFA—muscle cancer	0.00012	0.00062	CbGpPWpGaD
Melatonin—CALM1—Signaling by VEGF—VEGFA—muscle cancer	0.00012	0.00062	CbGpPWpGaD
Melatonin—CALM1—Signaling by ERBB2—MDM2—muscle cancer	0.00012	0.000617	CbGpPWpGaD
Melatonin—CALM2—Signaling by ERBB2—MDM2—muscle cancer	0.00012	0.000617	CbGpPWpGaD
Melatonin—CALM2—DAP12 signaling—MDM2—muscle cancer	0.000119	0.000614	CbGpPWpGaD
Melatonin—CALM1—DAP12 signaling—MDM2—muscle cancer	0.000119	0.000614	CbGpPWpGaD
Melatonin—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	0.000119	0.000611	CbGpPWpGaD
Melatonin—CALM3—DAP12 interactions—MDM2—muscle cancer	0.000116	0.000597	CbGpPWpGaD
Melatonin—CALM3—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	0.000116	0.000597	CbGpPWpGaD
Melatonin—CALM3—Signaling by FGFR in disease—MDM2—muscle cancer	0.000116	0.000597	CbGpPWpGaD
Melatonin—CALM3—Signaling by EGFR—MDM2—muscle cancer	0.000115	0.000592	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—KIT—muscle cancer	0.000115	0.000591	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—KIT—muscle cancer	0.000115	0.000591	CbGpPWpGaD
Melatonin—CALM3—Signaling by EGFR in Cancer—MDM2—muscle cancer	0.000114	0.000587	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—MED12—muscle cancer	0.000114	0.000585	CbGpPWpGaD
Melatonin—CALM3—Signaling by PDGF—MDM2—muscle cancer	0.000114	0.000584	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—KIDINS220—muscle cancer	0.000113	0.000583	CbGpPWpGaD
Melatonin—CALM2—Signaling by FGFR in disease—MDM2—muscle cancer	0.000112	0.000578	CbGpPWpGaD
Melatonin—CALM1—Signaling by FGFR in disease—MDM2—muscle cancer	0.000112	0.000578	CbGpPWpGaD
Melatonin—CALM2—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	0.000112	0.000578	CbGpPWpGaD
Melatonin—CALM1—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	0.000112	0.000578	CbGpPWpGaD
Melatonin—CALM1—DAP12 interactions—MDM2—muscle cancer	0.000112	0.000578	CbGpPWpGaD
Melatonin—CALM2—DAP12 interactions—MDM2—muscle cancer	0.000112	0.000578	CbGpPWpGaD
Melatonin—CALM2—Signaling by EGFR—MDM2—muscle cancer	0.000111	0.000573	CbGpPWpGaD
Melatonin—CALM1—Signaling by EGFR—MDM2—muscle cancer	0.000111	0.000573	CbGpPWpGaD
Melatonin—CALM1—Signaling by EGFR in Cancer—MDM2—muscle cancer	0.00011	0.000568	CbGpPWpGaD
Melatonin—CALM2—Signaling by EGFR in Cancer—MDM2—muscle cancer	0.00011	0.000568	CbGpPWpGaD
Melatonin—CALM2—Signaling by PDGF—MDM2—muscle cancer	0.00011	0.000565	CbGpPWpGaD
Melatonin—CALM1—Signaling by PDGF—MDM2—muscle cancer	0.00011	0.000565	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KIDINS220—muscle cancer	0.00011	0.000564	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KIDINS220—muscle cancer	0.00011	0.000564	CbGpPWpGaD
Melatonin—CALM3—Metabolism—FH—muscle cancer	0.000109	0.000562	CbGpPWpGaD
Melatonin—ESR1—Integrated Breast Cancer Pathway—TP53—muscle cancer	0.000108	0.000557	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000108	0.000553	CbGpPWpGaD
Melatonin—CALM3—B Cell Activation—MDM2—muscle cancer	0.000107	0.000553	CbGpPWpGaD
Melatonin—CALM2—Metabolism—FH—muscle cancer	0.000106	0.000543	CbGpPWpGaD
Melatonin—CALM1—Metabolism—FH—muscle cancer	0.000106	0.000543	CbGpPWpGaD
Melatonin—CALM3—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000105	0.000542	CbGpPWpGaD
Melatonin—CALM2—B Cell Activation—MDM2—muscle cancer	0.000104	0.000535	CbGpPWpGaD
Melatonin—CALM1—B Cell Activation—MDM2—muscle cancer	0.000104	0.000535	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—FH—muscle cancer	0.000104	0.000533	CbGpPWpGaD
Melatonin—CALM3—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.000103	0.000529	CbGpPWpGaD
Melatonin—CALM2—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000102	0.000524	CbGpPWpGaD
Melatonin—CALM1—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000102	0.000524	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—FOXO4—muscle cancer	0.000102	0.000524	CbGpPWpGaD
Melatonin—CALM3—Signaling by NGF—KIT—muscle cancer	0.0001	0.000517	CbGpPWpGaD
Melatonin—CALM2—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	9.95e-05	0.000512	CbGpPWpGaD
Melatonin—CALM1—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	9.95e-05	0.000512	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—MED12—muscle cancer	9.87e-05	0.000508	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—FOXO4—muscle cancer	9.85e-05	0.000507	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—FOXO4—muscle cancer	9.85e-05	0.000507	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	9.81e-05	0.000504	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—FOXO4—muscle cancer	9.78e-05	0.000503	CbGpPWpGaD
Melatonin—CALM2—Signaling by NGF—KIT—muscle cancer	9.72e-05	0.0005	CbGpPWpGaD
Melatonin—CALM1—Signaling by NGF—KIT—muscle cancer	9.72e-05	0.0005	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—MED12—muscle cancer	9.51e-05	0.000489	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—FOXO4—muscle cancer	9.46e-05	0.000486	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—FOXO4—muscle cancer	9.46e-05	0.000486	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—IGF2—muscle cancer	9.08e-05	0.000467	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—MDM2—muscle cancer	9.05e-05	0.000466	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—MDM2—muscle cancer	9.05e-05	0.000466	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—ENO2—muscle cancer	9e-05	0.000463	CbGpPWpGaD
Melatonin—ESR1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	8.98e-05	0.000462	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—IGF2—muscle cancer	8.78e-05	0.000452	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—IGF2—muscle cancer	8.78e-05	0.000452	CbGpPWpGaD
Melatonin—CALM3—Immune System—CD34—muscle cancer	8.72e-05	0.000449	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—ENO2—muscle cancer	8.67e-05	0.000446	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—FH—muscle cancer	8.48e-05	0.000436	CbGpPWpGaD
Melatonin—CALM1—Immune System—CD34—muscle cancer	8.44e-05	0.000434	CbGpPWpGaD
Melatonin—CALM2—Immune System—CD34—muscle cancer	8.44e-05	0.000434	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	8.38e-05	0.000431	CbGpPWpGaD
Melatonin—CALM3—Neuronal System—MDM2—muscle cancer	8.07e-05	0.000415	CbGpPWpGaD
Melatonin—CALM3—Signaling by NGF—MDM2—muscle cancer	7.91e-05	0.000407	CbGpPWpGaD
Melatonin—CALM1—Neuronal System—MDM2—muscle cancer	7.81e-05	0.000401	CbGpPWpGaD
Melatonin—CALM2—Neuronal System—MDM2—muscle cancer	7.81e-05	0.000401	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—FH—muscle cancer	7.73e-05	0.000398	CbGpPWpGaD
Melatonin—CALM2—Signaling by NGF—MDM2—muscle cancer	7.65e-05	0.000394	CbGpPWpGaD
Melatonin—CALM1—Signaling by NGF—MDM2—muscle cancer	7.65e-05	0.000394	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—PTCH1—muscle cancer	7.55e-05	0.000388	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—FOXO1—muscle cancer	7.52e-05	0.000387	CbGpPWpGaD
Melatonin—CALM3—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	7.38e-05	0.00038	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—PTCH1—muscle cancer	7.3e-05	0.000376	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—PTCH1—muscle cancer	7.3e-05	0.000376	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—FOXO1—muscle cancer	7.27e-05	0.000374	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—FOXO1—muscle cancer	7.27e-05	0.000374	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—FOXO1—muscle cancer	7.22e-05	0.000371	CbGpPWpGaD
Melatonin—CALM1—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	7.14e-05	0.000367	CbGpPWpGaD
Melatonin—CALM2—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	7.14e-05	0.000367	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	7.04e-05	0.000362	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—FOXO1—muscle cancer	6.99e-05	0.000359	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—FOXO1—muscle cancer	6.99e-05	0.000359	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—VEGFA—muscle cancer	6.87e-05	0.000353	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—VEGFA—muscle cancer	6.87e-05	0.000353	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	6.78e-05	0.000349	CbGpPWpGaD
Melatonin—CALM3—Disease—ENO2—muscle cancer	6.72e-05	0.000345	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—FH—muscle cancer	6.61e-05	0.00034	CbGpPWpGaD
Melatonin—CALM2—Disease—ENO2—muscle cancer	6.5e-05	0.000334	CbGpPWpGaD
Melatonin—CALM1—Disease—ENO2—muscle cancer	6.5e-05	0.000334	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PTCH1—muscle cancer	6.39e-05	0.000328	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—CNR1—muscle cancer	6.37e-05	0.000328	CbGpPWpGaD
Melatonin—CALM3—Metabolism—MED12—muscle cancer	6.17e-05	0.000317	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—CNR1—muscle cancer	6.16e-05	0.000317	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—CNR1—muscle cancer	6.16e-05	0.000317	CbGpPWpGaD
Melatonin—CALM3—Disease—HMGA1—muscle cancer	6.1e-05	0.000314	CbGpPWpGaD
Melatonin—CALM1—Metabolism—MED12—muscle cancer	5.97e-05	0.000307	CbGpPWpGaD
Melatonin—CALM2—Metabolism—MED12—muscle cancer	5.97e-05	0.000307	CbGpPWpGaD
Melatonin—CALM3—Immune System—FOXO4—muscle cancer	5.93e-05	0.000305	CbGpPWpGaD
Melatonin—CALM2—Disease—HMGA1—muscle cancer	5.91e-05	0.000304	CbGpPWpGaD
Melatonin—CALM1—Disease—HMGA1—muscle cancer	5.91e-05	0.000304	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—MED12—muscle cancer	5.85e-05	0.000301	CbGpPWpGaD
Melatonin—CALM1—Immune System—FOXO4—muscle cancer	5.74e-05	0.000295	CbGpPWpGaD
Melatonin—CALM2—Immune System—FOXO4—muscle cancer	5.74e-05	0.000295	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—KIT—muscle cancer	5.73e-05	0.000295	CbGpPWpGaD
Melatonin—CALM3—Metabolism—ENO2—muscle cancer	5.62e-05	0.000289	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—KIT—muscle cancer	5.54e-05	0.000285	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—KIT—muscle cancer	5.54e-05	0.000285	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—KIT—muscle cancer	5.5e-05	0.000283	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—FOXO4—muscle cancer	5.49e-05	0.000282	CbGpPWpGaD
Melatonin—CALM3—Disease—FOXO4—muscle cancer	5.48e-05	0.000282	CbGpPWpGaD
Melatonin—CALM1—Metabolism—ENO2—muscle cancer	5.44e-05	0.00028	CbGpPWpGaD
Melatonin—CALM2—Metabolism—ENO2—muscle cancer	5.44e-05	0.00028	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CNR1—muscle cancer	5.39e-05	0.000277	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—ENO2—muscle cancer	5.34e-05	0.000274	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—KIT—muscle cancer	5.32e-05	0.000274	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—KIT—muscle cancer	5.32e-05	0.000274	CbGpPWpGaD
Melatonin—CALM1—Disease—FOXO4—muscle cancer	5.3e-05	0.000272	CbGpPWpGaD
Melatonin—CALM2—Disease—FOXO4—muscle cancer	5.3e-05	0.000272	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—TP53—muscle cancer	5.19e-05	0.000267	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—TP53—muscle cancer	5.19e-05	0.000267	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—MED12—muscle cancer	4.79e-05	0.000246	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—MDM2—muscle cancer	4.51e-05	0.000232	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PTCH1—muscle cancer	4.46e-05	0.000229	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IGF2—muscle cancer	4.41e-05	0.000227	CbGpPWpGaD
Melatonin—CALM3—Immune System—FOXO1—muscle cancer	4.38e-05	0.000225	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—MED12—muscle cancer	4.37e-05	0.000225	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—ENO2—muscle cancer	4.37e-05	0.000225	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—MDM2—muscle cancer	4.37e-05	0.000224	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—MDM2—muscle cancer	4.37e-05	0.000224	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—MDM2—muscle cancer	4.33e-05	0.000223	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PTCH1—muscle cancer	4.31e-05	0.000222	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PTCH1—muscle cancer	4.31e-05	0.000222	CbGpPWpGaD
Melatonin—CALM2—Immune System—FOXO1—muscle cancer	4.24e-05	0.000218	CbGpPWpGaD
Melatonin—CALM1—Immune System—FOXO1—muscle cancer	4.24e-05	0.000218	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—MDM2—muscle cancer	4.19e-05	0.000216	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—MDM2—muscle cancer	4.19e-05	0.000216	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	4.17e-05	0.000215	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—FOXO1—muscle cancer	4.06e-05	0.000209	CbGpPWpGaD
Melatonin—CALM3—Disease—FOXO1—muscle cancer	4.04e-05	0.000208	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—ENO2—muscle cancer	3.98e-05	0.000205	CbGpPWpGaD
Melatonin—CALM1—Disease—FOXO1—muscle cancer	3.91e-05	0.000201	CbGpPWpGaD
Melatonin—CALM2—Disease—FOXO1—muscle cancer	3.91e-05	0.000201	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—FOXO4—muscle cancer	3.83e-05	0.000197	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—VEGFA—muscle cancer	3.81e-05	0.000196	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CNR1—muscle cancer	3.76e-05	0.000194	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—MED12—muscle cancer	3.73e-05	0.000192	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—FOXO4—muscle cancer	3.71e-05	0.000191	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—FOXO4—muscle cancer	3.71e-05	0.000191	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—VEGFA—muscle cancer	3.68e-05	0.000189	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—VEGFA—muscle cancer	3.68e-05	0.000189	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CNR1—muscle cancer	3.64e-05	0.000187	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CNR1—muscle cancer	3.64e-05	0.000187	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.42e-05	0.000176	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—ENO2—muscle cancer	3.4e-05	0.000175	CbGpPWpGaD
Melatonin—CALM3—Immune System—KIT—muscle cancer	3.34e-05	0.000172	CbGpPWpGaD
Melatonin—CALM1—Immune System—KIT—muscle cancer	3.23e-05	0.000166	CbGpPWpGaD
Melatonin—CALM2—Immune System—KIT—muscle cancer	3.23e-05	0.000166	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PTGS2—muscle cancer	3.13e-05	0.000161	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.11e-05	0.00016	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—KIT—muscle cancer	3.09e-05	0.000159	CbGpPWpGaD
Melatonin—CALM3—Disease—KIT—muscle cancer	3.08e-05	0.000158	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IGF2—muscle cancer	3.08e-05	0.000158	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PTGS2—muscle cancer	3.02e-05	0.000155	CbGpPWpGaD
Melatonin—CALM2—Disease—KIT—muscle cancer	2.98e-05	0.000153	CbGpPWpGaD
Melatonin—CALM1—Disease—KIT—muscle cancer	2.98e-05	0.000153	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IGF2—muscle cancer	2.98e-05	0.000153	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IGF2—muscle cancer	2.98e-05	0.000153	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—TP53—muscle cancer	2.88e-05	0.000148	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—FOXO1—muscle cancer	2.83e-05	0.000146	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—TP53—muscle cancer	2.78e-05	0.000143	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—TP53—muscle cancer	2.78e-05	0.000143	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—FOXO1—muscle cancer	2.74e-05	0.000141	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—FOXO1—muscle cancer	2.74e-05	0.000141	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.66e-05	0.000137	CbGpPWpGaD
Melatonin—CALM3—Immune System—MDM2—muscle cancer	2.63e-05	0.000135	CbGpPWpGaD
Melatonin—CALM2—Immune System—MDM2—muscle cancer	2.54e-05	0.000131	CbGpPWpGaD
Melatonin—CALM1—Immune System—MDM2—muscle cancer	2.54e-05	0.000131	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MDM2—muscle cancer	2.43e-05	0.000125	CbGpPWpGaD
Melatonin—CALM3—Disease—MDM2—muscle cancer	2.43e-05	0.000125	CbGpPWpGaD
Melatonin—CALM2—Disease—MDM2—muscle cancer	2.35e-05	0.000121	CbGpPWpGaD
Melatonin—CALM1—Disease—MDM2—muscle cancer	2.35e-05	0.000121	CbGpPWpGaD
Melatonin—CALM3—Disease—PTGS2—muscle cancer	2.34e-05	0.00012	CbGpPWpGaD
Melatonin—CALM2—Disease—PTGS2—muscle cancer	2.26e-05	0.000116	CbGpPWpGaD
Melatonin—CALM1—Disease—PTGS2—muscle cancer	2.26e-05	0.000116	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—KIT—muscle cancer	2.16e-05	0.000111	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KIT—muscle cancer	2.09e-05	0.000107	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KIT—muscle cancer	2.09e-05	0.000107	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PTGS2—muscle cancer	1.96e-05	0.000101	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PTGS2—muscle cancer	1.9e-05	9.75e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PTGS2—muscle cancer	1.9e-05	9.75e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PTGS2—muscle cancer	1.86e-05	9.56e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—VEGFA—muscle cancer	1.85e-05	9.51e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MDM2—muscle cancer	1.7e-05	8.74e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MDM2—muscle cancer	1.64e-05	8.45e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MDM2—muscle cancer	1.64e-05	8.45e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PTGS2—muscle cancer	1.52e-05	7.82e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TP53—muscle cancer	1.4e-05	7.18e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTGS2—muscle cancer	1.39e-05	7.13e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—VEGFA—muscle cancer	1.29e-05	6.64e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—VEGFA—muscle cancer	1.25e-05	6.42e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—VEGFA—muscle cancer	1.25e-05	6.42e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTGS2—muscle cancer	1.19e-05	6.1e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TP53—muscle cancer	9.75e-06	5.01e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TP53—muscle cancer	9.43e-06	4.85e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TP53—muscle cancer	9.43e-06	4.85e-05	CbGpPWpGaD
